NANETS produces a monthly eNewsletter, Net News. Net News contains information on recent NET disease research, guidelines and resources. It also highlights NET continuing medical education (CME) programming, medical society developments, member accomplishments and news from other NET organizations. Have news to share? Contact us! Net News is a benefit of membership in NANETS. Not a member? Subscribe now!

 NANETS is now accepting abstract submissions for the 2021 Multidisciplinary NET Medical Symposium, from November 4-6, 2021, in Chicago, IL, US. The abstract submission portal is open through July 30, 12:00 AM PDT. Click here to see full instructions.

NANETS' Annual Multidisciplinary NET Medical Symposium represents an excellent opportunity to present research relevant to cutting edge topics in neuroendocrine tumor research. Medical researchers at institutions in North America and around the world are invited to submit.

For examples of successful abstracts, we encourage you to visit our website. Interested professionals can access the abstract submission portal here.

NANETS is pleased to announce registration for the Annual Symposium is now open and is hosted at the Chicago Marriott Downtown Magnificent Mile November 4-6 in Chicago, IL.

chidt exterior 0227 hor clscChicagoMarriott

NANETS' Symposium provides a forum for members of the professional neuroendocrine community to discuss new diagnostic and therapeutic techniques, optimal multidisciplinary care, and the future of neuroendocrine tumor research.
Join over 500 medical professionals for three days of multidisciplinary, accredited medical education. Register by July 30 to gain access to the early bird rate. Registration for Symposium includes a one-year NANETS membership for nonmembers. Visit our website to access the program, hotel information, sponsor and exhibitor details, and much more.

Wednesday, June 16, Mark Lewis, MD was a guest on This Pathological Life Podcast where he discussed MEN Syndromes and how "pancreatic cancer need not to be viewed as a death sentence." Listen now on Apple Podcasts and Spotify.  

"The recognition of hereditary NET syndromes can be a tip-of-the-iceberg phenomenon whereby identifying a genetic cause of neuroendocrine tumors can affect the lifelong management of the index patient and lead to the discovery of affected relatives, with the opportunity to provide genetic counseling and potentially intervene earlier in a disease arising from a germline mutation," shares Dr. Lewis.